Human Health Impacts and Tissue Deposition of Microplastics and Nanoplastics: Organ-System Summary (April 2026)

Microplastics (1–5,000 µm) and nanoplastics (<1 µm) have been detected in multiple human tissues and organs, indicating systemic exposure through inhalation, ingestion, and other routes. Emerging evidence suggests nanoplastics may pose greater hazards than microplastics due to dramatically higher accessible surface area, which enhances cellular uptake, oxidative stress, inflammation, barrier penetration, and tissue reactivity. Key findings include: • Brain: detected in olfactory bulb and brain tissue; potential links to neurodegenerative pathways. • Heart & vasculature: present in plaques and thrombi; associated with increased cardiovascular events. • Lungs: deposited via inhalation; linked to local inflammation. • Liver, kidneys, GI tract: high accumulation sites; possible roles in organ dysfunction and colorectal cancer. • Reproductive tissues: detected in testes, ovaries, and semen; fertility concerns noted. • Blood: quantifiable systemic circulation; serves as a clinically relevant matrix for exposure assessment. While causation has not been established, these associations highlight the need for scalable, routine monitoring of micro- and nanoplastics in human matrices. Policy and public-health strategies should prioritize surface-area-aware risk assessment, capture-and-removal approaches, and non-invasive exposure tracking to better protect population health.